
Raman Govindarajan
About Raman Govindarajan
Data last updated:
Raman Govindarajan is a Director at Trucan Diagnostics Private Limited (since 2024) and Director at Samrud Foundation For Health & Research (since 2018). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹3.9 Lakh; the largest is Trucan Diagnostics Private Limited at ₹3.9 Lakh (FY 2026). Earlier, Raman Govindarajan was a Director at Jivagen Biotherapeutics Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jan 2024 | 2024 | ₹3.9 Lakh (FY 2026) | Active | |
| Director | 22 May 2018 | 2011 | ₹5,000 (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Raman Govindarajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hema Raman | 06772026 | Trucan Diagnostics Private Limited , Samrud Foundation For Health & Research | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raman Govindarajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raman Govindarajan
Raman Govindarajan currently holds 2 directorships: Trucan Diagnostics Private Limited (Director, since 05 Jan 2024, revenue ₹3.9 Lakh (FY 2026)); Samrud Foundation For Health & Research (Director, since 22 May 2018, revenue ₹5,000 (FY 2026)).
Raman Govindarajan was first appointed on 24 Jun 2017 as Director at Jivagen Biotherapeutics Private Limited. The most recent appointment on record is 05 Jan 2024 at Trucan Diagnostics Private Limited.
The 2 current companies of Raman Govindarajan that report revenue have a combined latest revenue of ₹3.9 Lakh: Trucan Diagnostics Private Limited ₹3.9 Lakh (FY 2026); Samrud Foundation For Health & Research ₹5,000 (FY 2026).
Raman Govindarajan held 1 earlier board appointment: Jivagen Biotherapeutics Private Limited (Director, from 24 Jun 2017).
The current boards of Raman Govindarajan's companies include Hema Raman (Trucan Diagnostics Private Limited).